173 related articles for article (PubMed ID: 7655575)
1. Platelet phenotyping in carriers for Glanzmann's thrombasthenia: a simple screening test for assessment of the molecular defect.
Morel-Kopp MC; Clemenceau S; Schlegel N; Lecompte T; Aurousseau MH; Kaplan C
Transfus Med; 1995 Jun; 5(2):123-9. PubMed ID: 7655575
[TBL] [Abstract][Full Text] [Related]
2. Immunological study of platelet glycoproteins and alloantigens in families of patients with Glanzmann's thrombasthenia.
Boizard-Boval B; Wautier JL; Gruel Y; Caen JP
Nouv Rev Fr Hematol (1978); 1992; 34(1):93-8. PubMed ID: 1523103
[TBL] [Abstract][Full Text] [Related]
3. Human platelet alloantigen polymorphism in Glanzmann's thrombasthenia and its impact on the severity of the disease.
Ghosh K; Kulkarni B; Nair S; Shetty S; Mohanty D
Br J Haematol; 2002 Nov; 119(2):348-53. PubMed ID: 12406067
[TBL] [Abstract][Full Text] [Related]
4. Genotyping provides a reliable tool for the determination of the platelet antigen system HPA-1 in Glanzmann's thrombasthenia.
Pober M; Kyrle PA; Panzer S
Br J Haematol; 1993 Sep; 85(1):112-5. PubMed ID: 8251377
[TBL] [Abstract][Full Text] [Related]
5. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
Fournier DJ; Kabral A; Castaldi PA; Berndt MC
Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
[TBL] [Abstract][Full Text] [Related]
6. Glanzmann's thrombasthenia caused by homozygosity for a splice defect that leads to deletion of the first coding exon of the glycoprotein IIIa mRNA.
Simsek S; Heyboer H; de Bruijne-Admiraal LG; Goldschmeding R; Cuijpers HT; von dem Borne AE
Blood; 1993 Apr; 81(8):2044-9. PubMed ID: 8471765
[TBL] [Abstract][Full Text] [Related]
7. Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods.
Morel-Kopp MC; Clemenceau S; Aurousseau MH; Schlegel N; Kaplan C
Transfus Med; 1994 Mar; 4(1):9-14. PubMed ID: 7912136
[TBL] [Abstract][Full Text] [Related]
8. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
[TBL] [Abstract][Full Text] [Related]
9. A three amino acid deletion in glycoprotein IIIa is responsible for type I Glanzmann's thrombasthenia: importance of residues Ile325Pro326Gly327 for beta3 integrin subunit association.
Morel-Kopp MC; Kaplan C; Proulle V; Jallu V; Melchior C; Peyruchaud O; Aurousseau MH; Kieffer N
Blood; 1997 Jul; 90(2):669-77. PubMed ID: 9226167
[TBL] [Abstract][Full Text] [Related]
10. Normal synthesis and expression of endothelial IIb/IIIa in Glanzmann's thrombasthenia.
Giltay JC; Leeksma OC; Breederveld C; van Mourik JA
Blood; 1987 Mar; 69(3):809-12. PubMed ID: 3545321
[TBL] [Abstract][Full Text] [Related]
11. Bilateral linkage between a new deletion polymorphism in intron 21 of the GP IIb gene and the HPA-3b (Bakb) determinant.
Peyruchaud O; Nurden A; Bourre F
Br J Haematol; 1995 Nov; 91(3):747-51. PubMed ID: 8555087
[TBL] [Abstract][Full Text] [Related]
12. Two human antibodies reacting with different epitopes on integrin beta 3 of platelets and endothelial cells.
Jallu V; Diaz-Ricart M; Ordinas A; Pico M; Vezon G; Nurden AT
Eur J Biochem; 1994 Jun; 222(3):743-51. PubMed ID: 7517865
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein IIb-IIIa complex in platelets of patients and heterozygotes of Glanzmann's thrombasthenia.
Herrmann FH; Meyer M; Gogstad GO; Solum NO
Thromb Res; 1983 Dec; 32(6):615-22. PubMed ID: 6229900
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: a proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex.
Kato A; Yamamoto K; Miyazaki S; Jung SM; Moroi M; Aoki N
Blood; 1992 Jun; 79(12):3212-8. PubMed ID: 1317725
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay.
Disdier M; Legrand C; Bouillot C; Dubernard V; Pidard D; Nurden AT
Thromb Res; 1989 Mar; 53(6):521-33. PubMed ID: 2499944
[TBL] [Abstract][Full Text] [Related]
16. Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.
Zahran AM; Saad K; Elsayh KI; Alblihed MA; Embaby M
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):565-571. PubMed ID: 28161816
[TBL] [Abstract][Full Text] [Related]
17. Detection of carriers in Glanzmann's thrombasthenia.
Zonneveld GT; van Leeuwen EF; Sturk A; ten Cate JW
Thromb Haemost; 1983 Jun; 49(3):182-6. PubMed ID: 6224309
[TBL] [Abstract][Full Text] [Related]
18. Diversity of glycoprotein deficiencies in Glanzmann's thrombasthenia.
Meyer M; Herrmann FH
Thromb Haemost; 1985 Oct; 54(3):626-9. PubMed ID: 2935964
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Glanzmann's thrombasthenia and carrier detection using monoclonal antibodies to platelet glycoprotein IIb and IIIa in immunoblotting.
Perutelli P; Marchese P; Mori PG
Haemostasis; 1992; 22(6):330-3. PubMed ID: 1478543
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an antibody to the integrin beta 3 subunit (GP IIIa) from a patient with neonatal thrombocytopenia and an inherited deficiency of GP IIb-IIIa complexes in platelets (Glanzmann's thrombasthenia).
Jallu V; Pico M; Chevaleyre J; Vézon G; Kunicki TJ; Nurden AT
Hum Antibodies Hybridomas; 1992 Apr; 3(2):93-106. PubMed ID: 1633270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
